Details for New Drug Application (NDA): 205029
✉ Email this page to a colleague
The generic ingredient in EPINEPHRINE is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
Summary for 205029
Tradename: | EPINEPHRINE |
Applicant: | Bpi Labs |
Ingredient: | epinephrine |
Patents: | 3 |
Pharmacology for NDA: 205029
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Medical Subject Heading (MeSH) Categories for 205029
Suppliers and Packaging for NDA: 205029
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 205029 | NDA | Henry Schein, Inc. | 0404-9857 | 0404-9857-01 | 1 AMPULE in 1 BAG (0404-9857-01) / 1 mL in 1 AMPULE |
EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 205029 | NDA | A-S Medication Solutions | 50090-3039 | 50090-3039-0 | 25 AMPULE in 1 BOX (50090-3039-0) / 1 mL in 1 AMPULE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | Strength | 1MG/ML (1MG/ML) | ||||
Approval Date: | Jul 29, 2014 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 14, 2034 | Product Flag? | Y | Substance Flag? | Delist Request? | Y | |
Patented Use: | EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE 1), INCLUDING ANAPHYLAXIS; A METHOD OF TREATING ALLERGIC REACTION, ANAPHYLAXIS, ANAPHYLACTIC SHOCK, OR COMBINATION THEREOF BY AN INJECTION OF AT LEAST ONE DOSAGE OF THE INJECTABLE LIQUID PHARMACEUTICAL | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 14, 2034 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patented Use: | INCREASING MEAN ARTERIAL BLOOD PRESSURE IN ADULT PATIENTS WITH HYPOTENSION ASSOCIATED WITH SEPTIC SHOCK | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 15, 2034 | Product Flag? | Y | Substance Flag? | Delist Request? | Y | |
Patented Use: | EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS |
Complete Access Available with Subscription